248 related articles for article (PubMed ID: 25854796)
1. β-blocker use and mortality in COPD patients after myocardial infarction: a Swedish nationwide observational study.
Andell P; Erlinge D; Smith JG; Sundström J; Lindahl B; James S; Koul S
J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25854796
[TBL] [Abstract][Full Text] [Related]
2. Effect of β blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records.
Quint JK; Herrett E; Bhaskaran K; Timmis A; Hemingway H; Wedzicha JA; Smeeth L
BMJ; 2013 Nov; 347():f6650. PubMed ID: 24270505
[TBL] [Abstract][Full Text] [Related]
3. β-Blocker Use and Clinical Outcomes in Patients With COPD Following Acute Myocardial Infarction.
LaFon DC; Helgeson ES; Lindberg S; Voelker H; Bhatt SP; Casaburi R; Cassady SJ; Connett J; Criner GJ; Hatipoglu U; Kaminsky DA; Kunisaki KM; Lazarus SC; McEvoy CE; Reed RM; Sciurba FC; Stringer W; Dransfield MT
JAMA Netw Open; 2024 May; 7(5):e247535. PubMed ID: 38771577
[TBL] [Abstract][Full Text] [Related]
4. Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative.
Coiro S; Girerd N; Rossignol P; Ferreira JP; Maggioni A; Pitt B; Tritto I; Ambrosio G; Dickstein K; Zannad F
Eur J Heart Fail; 2017 Feb; 19(2):271-279. PubMed ID: 27774703
[TBL] [Abstract][Full Text] [Related]
5. Beta-blocker use and acute exacerbations of COPD following myocardial infarction: a Danish nationwide cohort study.
Rasmussen DB; Bodtger U; Lamberts M; Torp-Pedersen C; Gislason G; Lange P; Jensen MT
Thorax; 2020 Nov; 75(11):928-933. PubMed ID: 32820080
[TBL] [Abstract][Full Text] [Related]
6. Beta-blocker, aspirin, and statin usage after first-time myocardial infarction in patients with chronic obstructive pulmonary disease: a nationwide analysis from 1995 to 2015 in Denmark.
Rasmussen DB; Bodtger U; Lamberts M; Nicolaisen SK; Sessa M; Capuano A; Torp-Pedersen C; Gislason G; Lange P; Jensen MT
Eur Heart J Qual Care Clin Outcomes; 2020 Jan; 6(1):23-31. PubMed ID: 30608575
[TBL] [Abstract][Full Text] [Related]
7. β-blockers after myocardial infarction and 1-year clinical outcome - a retrospective study.
Hagsund T; Olsson SE; Smith JG; Madsen Hardig B; Wagner H
BMC Cardiovasc Disord; 2020 Apr; 20(1):165. PubMed ID: 32272880
[TBL] [Abstract][Full Text] [Related]
8. Improving outcomes in chronic obstructive pulmonary disease by taking beta-blockers after acute myocardial infarction: a nationwide observational study.
Wang WH; Cheng CC; Mar GY; Wei KC; Huang WC; Liu CP
Heart Vessels; 2019 Jul; 34(7):1158-1167. PubMed ID: 30680495
[TBL] [Abstract][Full Text] [Related]
9. Cardioselective Versus Nonselective β-Blockers After Myocardial Infarction in Adults With Chronic Obstructive Pulmonary Disease.
Chung CM; Lin MS; Chang ST; Wang PC; Yang TY; Lin YS
Mayo Clin Proc; 2022 Mar; 97(3):531-546. PubMed ID: 35135688
[TBL] [Abstract][Full Text] [Related]
10. β-blockers after acute myocardial infarction in patients with chronic obstructive pulmonary disease: A nationwide population-based observational study.
Su TH; Chang SH; Kuo CF; Liu PH; Chan YL
PLoS One; 2019; 14(3):e0213187. PubMed ID: 30835781
[TBL] [Abstract][Full Text] [Related]
11. Benefit of Vasodilating β-Blockers in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention: Nationwide Multicenter Cohort Study.
Chung J; Han JK; Kim YJ; Kim CJ; Ahn Y; Chan Cho M; Chae SC; Chae IH; Chae JK; Seong IW; Yang HM; Park KW; Kang HJ; Koo BK; Jeong MH; Kim HS;
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066446
[TBL] [Abstract][Full Text] [Related]
12. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
[TBL] [Abstract][Full Text] [Related]
13. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry.
Motivala AA; Parikh V; Roe M; Dai D; Abbott JD; Prasad A; Mukherjee D
JACC Cardiovasc Interv; 2016 Aug; 9(16):1639-48. PubMed ID: 27539683
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma.
Chen J; Radford MJ; Wang Y; Marciniak TA; Krumholz HM
J Am Coll Cardiol; 2001 Jun; 37(7):1950-6. PubMed ID: 11401137
[TBL] [Abstract][Full Text] [Related]
15. Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study.
Short PM; Lipworth SI; Elder DH; Schembri S; Lipworth BJ
BMJ; 2011 May; 342():d2549. PubMed ID: 21558357
[TBL] [Abstract][Full Text] [Related]
16. β-blocker use in patients after percutaneous coronary interventions: one size fits all? Worse outcomes in patients without myocardial infarction or heart failure.
Ozasa N; Morimoto T; Bao B; Furukawa Y; Nakagawa Y; Kadota K; Iwabuchi M; Shizuta S; Shiomi H; Tazaki J; Natsuaki M; Kimura T;
Int J Cardiol; 2013 Sep; 168(2):774-9. PubMed ID: 23127614
[TBL] [Abstract][Full Text] [Related]
17. Association between β-blocker dose and cardiovascular outcomes after myocardial infarction: insights from the SWEDEHEART registry.
Mars K; Wallert J; Held C; Humphries S; Pingel R; Jernberg T; Olsson EMG; Hofmann R
Eur Heart J Acute Cardiovasc Care; 2021 May; 10(4):372-379. PubMed ID: 33620439
[TBL] [Abstract][Full Text] [Related]
18. Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.
Figtree GA; Vernon ST; Hadziosmanovic N; Sundström J; Alfredsson J; Arnott C; Delatour V; Leósdóttir M; Hagström E
Lancet; 2021 Mar; 397(10279):1085-1094. PubMed ID: 33711294
[TBL] [Abstract][Full Text] [Related]
19. Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF).
Mentz RJ; Wojdyla D; Fiuzat M; Chiswell K; Fonarow GC; O'Connor CM
Am J Cardiol; 2013 Feb; 111(4):582-7. PubMed ID: 23200803
[TBL] [Abstract][Full Text] [Related]
20. Comparative Effectiveness of β-Blocker Use Beyond 3 Years After Myocardial Infarction and Long-Term Outcomes Among Elderly Patients.
Shavadia JS; Holmes DN; Thomas L; Peterson ED; Granger CB; Roe MT; Wang TY
Circ Cardiovasc Qual Outcomes; 2019 Jul; 12(7):e005103. PubMed ID: 31284739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
